{"schema_version":"1","generated_at":"2026-11-01T08:12:00.777Z","data_as_of":null,"url":"https://www.findmykol.com/kol/omobolaji-akala","json_url":"https://www.findmykol.com/kol/omobolaji-akala/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"omobolaji-akala","name":"Omobolaji Akala","credential":"MD/PHD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Merck & Co.","institution_url":"https://www.findmykol.com/institution/merck-co","city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1366735722","openalex":"A5054523405"},"summary":"Omobolaji Akala is an Oncology physician affiliated with Merck & Co.. OpenAlex indexes 29 publications with 410 citations (h-index 8).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":29,"cited_by_count":410,"h_index":8,"latest_activity_year":2025,"source":"works"},"publications":{"total":26,"shown":5,"withheld":21,"matched_by":"OpenAlex author record","recent":[{"title":"Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapies","year":2025,"journal":"Journal of Hematology & Oncology","source_url":"https://doi.org/10.1186/s13045-025-01705-2","status":"verified"},{"title":"Efficacy and safety of sacituzumab tirumotecan monotherapy in patients with advanced urothelial carcinoma who progressed on or after prior anti-cancer therapies: Report from the phase 1/2 MK-2870-001 study.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.5_suppl.796","status":"verified"},{"title":"Pharmacokinetics and bioavailability of pembrolizumab with berahyaluronidase alfa for subcutaneous administration in participants with advanced or metastatic solid tumors: The phase 1 study 3475A-C18","year":2025,"journal":"European Journal of Cancer","source_url":"https://doi.org/10.1016/j.ejca.2025.115709","status":"verified"},{"title":"Sacituzumab tirumotecan in participants with advanced or metastatic urothelial carcinoma and disease progression after chemotherapy and immune checkpoint inhibitors","year":2025,"journal":"Annals of Oncology","source_url":"https://doi.org/10.1016/j.annonc.2025.11.013","status":"verified"},{"title":"Abstract CT036: Bioavailability of MK-3475A (pembrolizumab with berahyaluronidase alfa; “subcutaneous pembrolizumab”) in participants with advanced or metastatic solid tumors","year":2025,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2025-ct036","status":"verified"}],"source":"works"},"contact":{"address_1":"630 W 168TH ST","address_2":"CUMC, NEW YORK PRESBYTERIAN HOSPITAL","city":"New York","state":"NY","zip":"100323725","phone":"212-305-2913","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1366735722","source":"identity"},"similar":[{"name":"Ednan Bajwa","slug":"ednan-bajwa","institution":"Merck & Co.","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/ednan-bajwa","json_url":"https://www.findmykol.com/kol/ednan-bajwa/profile.json"},{"name":"Annaswamy Raji","slug":"annaswamy-raji","institution":"Merck & Co.","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/annaswamy-raji","json_url":"https://www.findmykol.com/kol/annaswamy-raji/profile.json"},{"name":"Ritu Valiyil","slug":"ritu-valiyil","institution":"Merck & Co.","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/ritu-valiyil","json_url":"https://www.findmykol.com/kol/ritu-valiyil/profile.json"},{"name":"William F. Keane","slug":"william-keane","institution":"Merck & Co.","url":"https://www.findmykol.com/kol/william-keane","json_url":"https://www.findmykol.com/kol/william-keane/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":21}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-10-02","provider_certified":"2024-10-02","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}